BioSpace News Archive

Lone Star Bio

Nanoscope’s Vision Restoring Optogenetic Gene Therapy to be Featured in Multiple Presentations as part of ARVO Annual Meeting in Denver May. 1-4, 2022

Nanoscope Therapeutics Inc. announced four presentations on the Company’s preclinical and clinical research in retinitis pigmentosa and Stargardt macular degeneration at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting, being held May 1 – 4, 2022, in Denver, Colorado.

April 26, 2022
·
2 min read
Genetown

Zambon to present data on lung transplantation trends and survival rates in Europe at ISHLT 2022

Zambon is presenting two posters at the International Society for Heart and Lung Transplantation (ISHLT) Annual 2022 Meeting taking place April 27–30 in Boston, MA.

April 26, 2022
·
4 min read
Business

Vedere Bio II Appoints Accomplished Clinician and Researcher Anna-Maria Demetriades as Chief Medical Officer

Vedere Bio II, Inc. today announced the appointment of Anna-Maria Demetriades , M.D., Ph.D. as Chief Medical Officer.

April 26, 2022
·
3 min read
Biotech Bay

Veeva Link Adds Four New Data Applications to Deliver Real-time Intelligence for Medical and Commercial Teams

Veeva Systems announced new Veeva Link data applications for medical, commercial, and key account management teams to gain real-time intelligence on health systems, scientific awareness and sentiment, and medical insights.

April 26, 2022
·
3 min read
Business

Ambagon Therapeutics Appoints Gideon Bollag, Ph.D., to Scientific Advisory Board

Ambagon Therapeutics today announced the appointment of Gideon Bollag, Ph.D., to its Scientific Advisory Board.

April 26, 2022
·
3 min read
Business

Rockley Photonics Revises Date of First Quarter 2022 Financial Results Release

Rockley Photonics today announced that its first quarter 2022 financial results conference call has been rescheduled to after the market close on Thursday, May 12, 2022, to allow additional time to prepare its earnings report.

April 26, 2022
·
3 min read
Business

Saol Therapeutics and InformedDNA Partner to Offer Genetic Counseling to Patients with Rare Mitochondrial Disease

Saol Therapeutics is pleased to announce a partnership with InformedDNA® , the nation’s leading applied genomics solutions company, to offer genetic counseling for the families of individuals with a rare mitochondrial disease, Pyruvate Dehydrogenase Complex Deficiency (PDCD).

April 26, 2022
·
4 min read
Pharm Country

TG Therapeutics to Participate in the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference

TG Therapeutics, Inc., announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in a fireside chat during the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference, taking place on Thursday, April 28, 2022, at 12:30 PM ET.

April 26, 2022
·
1 min read
Business

Iovance Biotherapeutics to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 5, 2022

Iovance Biotherapeutics, Inc. will report its first quarter financial results on Thursday, May 5, 2022.

April 26, 2022
·
5 min read
Pharm Country

Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu

Holmusk is pleased to share with the scientific community in-depth details about its platform via the publication of a paper in BMJ Open.

April 26, 2022
·
4 min read